B. Lauby-secretan, C. Scoccianti, D. Loomis, L. Benbrahim-tallaa, V. Bouvard et al., Breast-Cancer Screening-Viewpoint of the IARC Working Group, N Engl J Med. 11 juin, vol.372, pp.2353-2361, 2015.

A. Tardivon and C. Malhaire, Cancer du sein (I). Épidémiologie, facteurs de risque, imagerie. Httpwwwem-Premiumcomdatatraitesr534-42047, vol.21, p.22, 2017.

. Disponible,

P. Pujol, Prédispositions Familiales Aux Cancers Du Sein: Familial Predisposition to Breast Cancer, Imag Femme, vol.14, issue.2, pp.141-144, 2004.

H. Meijers-heijboer, B. Van-geel, W. Van-putten, S. C. Henzen-logmans, C. Seynaeve et al., Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation, N Engl J Med. 19 juill, vol.345, issue.3, pp.159-64, 2001.

N. Hoogerbrugge, Y. Kamm, P. Bult, K. M. Landsbergen, E. Bongers et al., The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited, Ann Oncol Off J Eur Soc Med Oncol. avr, vol.19, issue.4, pp.655-664, 2008.

K. K. Ludwig, J. Neuner, A. Butler, J. L. Geurts, and A. L. Kong, Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review, Am J Surg, vol.212, issue.4, pp.660-669, 2016.

C. H. Lee, D. D. Dershaw, D. Kopans, P. Evans, B. Monsees et al., Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer, J Am Coll Radiol JACR. janv, vol.7, issue.1, pp.18-27, 2010.

, Familial Breast Cancer: The Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary and Tertiary Care: Update, 2006.

, Femmes porteuses d'une mutation de BRCA1 ou BRCA2 / Détection précoce du cancer du sein et des annexes et stratégies de réduction du risque-Ref : RECOBRCA17 | Institut National Du Cancer, p.23, 2017.

. Disponible,

H. Sobol, J. Jacquemier, D. Stoppa-lyonnet, F. Eisinger, and D. Birnbaum, Caractéristiques des cancers du sein héréditaires liés aux gènes BRCA1 et BRCA2: aspects moléculaires et morphologiques. Expert Collect FNCLCCINSERM Risques Héréditaires Cancer Sein L'ovaire Quelle Prise En Charge, pp.91-115, 1997.

. Imagerie-de-la-femme-:-sénologie, . Marc, and A. Tardivon, , p.23, 2017.

, The fourth EORTC DCIS Consensus meeting, pp.23-24, 1998.

V. L. Ernster, R. Ballard-barbash, W. E. Barlow, Y. Zheng, D. L. Weaver et al., Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography, JNCI J Natl Cancer Inst, vol.94, issue.20, pp.1546-54, 2002.

M. Boisserie-lacroix, V. Catena, and M. Depetiteville, Atlas BI-RADS ACR IRM 2013 : quels changements ? Imag Femme. 1 mars, vol.27, pp.16-24, 2017.

E. Warner, P. A. Causer, J. Wong, F. C. Wright, R. A. Jong et al., Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening Study: DCIS Detection Rates by MRI Over Time, Breast J. janv, vol.17, issue.1, pp.9-17, 2011.

C. K. Kuhl, S. Schrading, H. B. Bieling, E. Wardelmann, C. C. Leutner et al., MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study, Lancet Lond Engl. 11 août, vol.370, issue.9586, pp.485-92, 2007.

J. Krammer, K. Pinker-domenig, M. E. Robson, M. Gönen, B. Bernard-davila et al., Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers, Breast Cancer Res Treat. juin, vol.163, issue.3, pp.565-71, 2017.

C. T. Brekelmans, C. Seynaeve, C. C. Bartels, M. M. Tilanus-linthorst, E. J. Meijersheijboer et al., Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk, J Clin Oncol Off J Am Soc Clin Oncol. 15 févr, vol.19, issue.4, pp.924-954, 2001.

I. K. Komenaka, B. Ditkoff, K. Joseph, D. Russo, P. Gorroochurn et al., The development of interval breast malignancies in patients with BRCA mutations, Cancer. 15 mai, vol.100, issue.10, pp.2079-83, 2004.

H. Vasen, E. Tesfay, H. Boonstra, M. Mourits, E. Rutgers et al., Early detection of breast and ovarian cancer in families with BRCA mutations, Eur J Cancer. 1 mars, vol.41, issue.4, pp.549-54, 2005.

S. W. Fletcher and J. G. Elmore, Mammographic Screening for Breast Cancer, N Engl J Med. 24 avr, vol.348, issue.17, pp.1672-80, 2003.

, Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases, Lancet Lond Engl. 24 mai, vol.349, issue.9064, pp.1505-1515, 1997.

S. R. Lakhani, J. Jacquemier, J. P. Sloane, B. A. Gusterson, T. J. Anderson et al., Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations, J Natl Cancer Inst. 5 août, vol.90, issue.15, pp.1138-1183, 1998.

R. L. Yang, R. Mick, K. Lee, H. L. Graves, K. L. Nathanson et al., DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3, J Transl Med, vol.13, p.23, 2015.

E. Mazzola, S. Cheng, and G. Parmigiani, The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers, Breast Cancer Res Treat. janv, vol.137, issue.1, pp.315-323, 2013.

A. K. Narayan, K. Visvanathan, and S. C. Harvey, Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study, Breast Cancer Res Treat. août, vol.158, issue.3, pp.583-592, 2016.

I. Obdeijn, G. Winter-warnars, R. M. Mann, M. J. Hooning, M. Hunink et al., Should we screen BRCA1 mutation carriers only with MRI? A multicenter study, Breast Cancer Res Treat. avr, vol.144, issue.3, pp.577-82, 2014.

X. Phi, S. Saadatmand, D. Bock, G. H. Warner, E. Sardanelli et al., Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis, Br J Cancer. 15 mars, vol.114, issue.6, pp.631-638, 2016.

C. M. Checka, J. E. Chun, F. R. Schnabel, J. Lee, and H. Toth, The relationship of mammographic density and age: implications for breast cancer screening, AJR Am J Roentgenol. mars, vol.198, issue.3, pp.292-295, 2012.

J. Van-zelst, R. Mus, G. Woldringh, M. Rutten, P. Bult et al., Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography. Radiology, vol.285, pp.376-88, 2017.

D. G. Evans, E. D. Gareth, N. Kesavan, K. Nisha, Y. Lim et al., MRI breast screening in high-risk women: cancer detection and survival analysis, Breast Cancer Res Treat. juin, vol.145, issue.3, pp.663-72, 2014.

J. S. Sung, S. Stamler, J. Brooks, J. Kaplan, T. Huang et al., Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results, Radiology. 20 avr, vol.280, issue.3, pp.716-738, 2016.

C. C. Riedl, N. Luft, C. Bernhart, M. Weber, M. Bernathova et al., TripleModality Screening Trial for Familial Breast Cancer Underlines the Importance of Magnetic Resonance Imaging and Questions the Role of Mammography and Ultrasound Regardless of Patient Mutation Status, Age, and Breast Density, J Clin Oncol. avr, vol.33, issue.10, pp.1128-1163, 2015.

A. M. Chiarelli, M. V. Prummel, D. Muradali, V. Majpruz, M. Horgan et al., Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program, J Clin Oncol. 20 juill, vol.32, issue.21, pp.2224-2254, 2014.

K. Passaperuma, E. Warner, P. A. Causer, K. A. Hill, S. Messner et al., Long-term results of screening with magnetic resonance imaging in women with BRCA mutations, Br J Cancer. 26 juin, vol.107, issue.1, pp.24-30, 2012.

D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach et al., American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography, CA Cancer J Clin. avr, vol.57, issue.2, pp.75-89, 2007.

S. Bayraktar, N. Elsayegh, G. Barrera, A. M. Lin, H. Kuerer et al., Predictive Factors for BRCA1/BRCA2 Mutations in Women With Ductal Carcinoma In Situ, Cancer. 15 mars, vol.118, issue.6, pp.1515-1537, 2012.

E. S. Hwang, J. L. Mclennan, D. H. Moore, B. B. Crawford, L. J. Esserman et al., Ductal Carcinoma In Situ in BRCA Mutation Carriers, J Clin Oncol. 9 févr, vol.25, issue.6, pp.642-649, 2007.

E. P. Ward, A. Weiss, and S. L. Blair, Incidence and treatments of DCIS in octogenarians: grade matters, Breast Cancer Res Treat. 1 sept, vol.165, issue.2, pp.403-412, 2017.

E. Warner, D. B. Plewes, K. A. Hill, P. A. Causer, J. T. Zubovits et al., Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination, JAMA. 15 sept, vol.292, issue.11, pp.1317-1342, 2004.

E. Warner, D. B. Plewes, R. S. Shumak, G. C. Catzavelos, D. Prospero et al., Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer, J Clin Oncol Off J Am Soc Clin Oncol. 1 août, vol.19, issue.15, pp.3524-3555, 2001.

P. Chérel, H. Berment, D. Maulmont, C. Khayat, R. Langer et al., Gestion des microcalcifications dans le contexte de femmes à risque de cancer du sein, Imag Femme. 1 déc, vol.20, issue.4, pp.185-91, 2010.

B. N. Dontchos, H. Rahbar, S. C. Partridge, L. A. Korde, D. L. Lam et al., Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk?, Radiology. 12 mai, vol.276, issue.2, pp.371-80, 2015.